Perm Medical Journal · Jul 10, 2026
Sarcopenia in patients with kidney disease: controversial and unresolved issues in diagnosis and treatment
By Romanova TN, Kazarinov AV, Карпунина НС
Current knowledge on sarcopenia in chronic kidney disease (CKD), with particular focus on unresolved issues in the diagnosis and management of sarcopenia is summarized. An analytical review of recent publications on sarcopenia in CKD was conducted, covering prevalence, pathogenesis, diagnostic approaches, and treatment. The analysis included reviews, meta-analyses, consensus documents, and original studies reflecting current approaches in nephrology and geriatrics, including data on sarcopenia in patients at predialysis stage, on dialysis, and after kidney transplantation. Sarcopenia is reported in 5–62 % of patients with CKD, with the highest prevalence observed in advanced stages and among those receiving renal replacement therapy. Pathogenetic mechanisms include uremic toxicity, chronic inflammation, hormonal imbalance, metabolic acidosis, and malnutrition. Diagnosis remains controversial: although EWGSOP2, AWGS, and FNIH provide stepwise approaches, no universal standard exists, which complicates cross-study comparisons and routine clinical implementation. Bioelectrical impedance analysis is widely used due to its accessibility and reproducibility; however, its accuracy may be compromised in patients with significant fluid imbalance. Therapeutic approaches are heterogeneous. Evidence supports the benefits of nutritional optimization, physical activity, and dietary supplementation. However, the optimal protein intake, the roles of vitamin D and omega-3 fatty acids, and the efficacy of emerging pharmacological therapies (myostatin inhibitors, hormonal agents) remain debated. Sarcopenia in CKD is a major interdisciplinary issue with a strong impact on patient prognosis and quality of life. Early recognition and multimodal management can reduce disability and mortality risks. Nonetheless, further research is required to refine diagnostic criteria, standardize assessment tools, and establish effective preventive and therapeutic protocols.